United States · FDA National Drug Code directory
Atovaquone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68999-528_430808cb-6a2f-94ee-e063-6394a90ab6fd
- Product NDC
- 68999-528
- Form
- SUSPENSION
- Composition / generic term
- Atovaquone
- Labeler
- Chartwell Governmental & Specialty RX, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170428
- Source listing expiry
- 20261231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TRAY in 1 BOX (68999-528-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-528-45) · 68999-528-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →